Skip to main content
Clinical Trials/NCT03723629
NCT03723629UnknownNot Applicable

Progression of Untreated Pulmonary Ground Glass Opacity

Shanghai Zhongshan Hospital1 site in 1 country2,000 target enrollmentStarted: July 27, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
2,000
Locations
1
Primary Endpoint
Changes from baseline GGO diameter

Study Overview

Brief Summary

In this study, about 2000 GGO patients will be included for a 5-year follow-up. The aim of this study is to elucidate the biological nature of pulmonary GGO lesion and provide evidence for GGO treatment.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
35 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •35-80 years' old
  • •found pulmonary GGO with chest CT scan and CT follow-up after 3 months shows that the GGO remains
  • •Diameter of GGO > 5mm and < 3cm
  • •Solid component of GGO in pulmonary window < 5mm
  • •signed informed consent form

Exclusion Criteria

  • •receiving immunosuppressor or steriods
  • •receiving chemo- or radio- therapy
  • •can not receive regular follow-up

Outcomes

Primary Outcomes

Changes from baseline GGO diameter

Time Frame: 6 months, 1year, 2 years, 3 years, 4 years and 5 years

Changes from baseline GGO diameter

Changes from baseline GGO CT index.

Time Frame: 6 months, 1year, 2 years, 3 years, 4 years and 5 years

Changes from baseline GGO CT index.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Shanghai Zhongshan Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials